Cancer of the uterine corpus is the most common malignancy of female pelvic genital organs. Increasing incidence of carcinoma of the endometrium has been apparent in recent years (Creasman, 1992) . Generally accepted histological parameters of prognostic value are histological grade, depth of myometrial invasion, histological variant, lymphatic and vascular invasion, pelvic and para-aortal nodal status and clinical-surgical stage (Baltzer et al., 1983; Christopherson et al., 1983; Hendricson et al., 1982; Ng and Reegan, 1970) . The influence of ovarian steroid hormones in the development of abnormal proliferation of the endometrium is recognised. The presence of steroid hormone receptors is of prognostic importance, oestrogen and progesterone receptor status are reported to be an independent prognostic factor for diseasefree survival (Clement and Scully, 1993) . Progesterone receptor-positive tumours appear to be more responsive to therapy with progestin, whereas others may be more responsive to chemotherapy (Creasman, 1993) .
Cathepsin D is an oestrogen-dependent lysosomal protease in breast tissues that facilitates tumour invasion by promoting breakdown of connective tissue and basal membrane (Rochefort et al., 1987) . In the normal human endometrium progesterone induces the accumulation of cathepsin D. Cathepsin D levels are higher in normal human endometrium during the luteal phase than in the follicular phase and increase slightly during pregnancy (Maudelonde et al., 1990) . In endometrial adenocarcinoma cathepsin D levels are higher than in normal endometrium during the follicular phase, but there is no correlation to steroid hormone receptor status (Maudelonde et al., 1990; Nazeer et al., 1994) .
Cathepsin D is a well-known independent prognostic factor in breast cancer, associated with metastasis and overall survival (Spyratos et al., 1989; Tandon et al., 1990; Thorpe et al., 1989) . Limited information is available on the prognostic value of cathepsin D regarding gynaecological malignancies. We investigated the prognostic value of cathepsin D in 115 cases of endometrial cancer by immunohistochemistry.
Materials and methods
A total of 115 patients with surgically treated endometrial adenocarcinoma FIGO stages I -III were included in the study. Mean age was 64.3 (s.d. 9.6, minimum 36, maximum 85) . Seven patients had a premenopausal hormonal status. None of the post-menopausal women received hormonal replacement therapy during the last 3 months before surgical treatment. Diagnosis was established in all cases preoperatively by dilatation and curettage. All patients were treated by total abdominal hysterectomy, bilateral salpingo-oophorectomy between 1980 and 1989. In the seven premenopausal patients surgical treatment was performed in four cases, two at the follicular phase and two at the luteal phase of the menstrual cycle. In the remaining three cases irregular bleedings were the reason for unclear stage of the menstrual cycle at the time of hysterectomy. Serous papillary endometrial tumours were excluded. Lymph node staging was not performed routinely during the whole observation period and could therefore not be included in further analysis. In cases of patients with stage I endometrial adenocarcinoma the decision whether they received vaginal contact radiation only or additional percutaneous pelvic lymph node radiation depended on risk factors such as tumour infiltration exceeding one-third of the myometrium, high-grade tumour and vascular invasion. All patients in advanced stages received both local and percutaneous radiation treatment. For the after-loading method, iridium-192 was used (2-3 x 7 Gy). Where post-surgical external radiation was incorporated using cobalt-60, we tried to achieve doses of 56 Gy at the pelvis. The endometrial biopsy, uterus, ovaries and lymph node specimens were examined for tumour type, grade and stage according to the International Federation of Gynaecology and Obstetrics system (FIGO, 1990 ). All patients were followed up for at least 5 years and some up to 13 years.
Immunohistochemistry
We performed immunohistochemistry using the primary intracellular staining of the antibody proves immunoreactivity of the precursor and the activated form of the enzyme in the cytoplasm. The antibody stains macrophages, normal fibroblasts, preferentially glandular epithelium such as sweat ducts and glands in skin and myoepithelial cells of nonlactating mammary glands. In breast cancer tumours this antibody shows staining of variable intensity.
All sections tested are routine formalin-fixed paraffinembedded samples. Paraffin sections were soaked in xylene to remove paraffin and rehydrated in graded alcohol series (100-70%). To recover antigenicity we used the Antigen Retrieval System (Bio Genex, San Ramon, CA, USA) twice for 5 min in the microwave on high power (600 W), sections were then washed in 10 mm phosphate-buffered saline (PBS) (pH 7.6). The sections were incubated with cathepsin D antiserum at 1:300 dilution for 60 min, then for a further 30 min with biotinylated anti-mouse and anti-rabbit link antibody (Dako LSAB 2 Kit). After rinsing in PBS the sections were coated wuLh streptavidin conjugated to alkaline phosphatase for 10 min. The sections were rinsed in PBS, incubated with fast red chromogen (naphthol phosphate substrate in Tris buffer, fast red chromogen tablets 5 mg, BioGenex) and then washed in distilled water. The sections were finally counterstained with haematoxylin and mounted.
Control: the positive control slide was prepared from skin tissue. In skin the antibody labels sweat ducts and glands. The negative control slide was prepared from the same tissue block as the specimen. Instead of using a primary antibody we used a non-immune rabbit serum (Dako code no., X902, 69 mg ml ' diluted 1:600.
We used a semiquantitative method to determine immunoreactivity. In endometrial tumours more than 10% of strong and/or widespread intracellular cytoplasmic staining was interpreted as positive (Figure 1 ). Weak and focal staining less than 10% was regarded as a negative reaction. Occasionally surrounding stromal tissue showed a positive reaction. Macrophages and normal fibroblasts stained strongly.
Statistical wnalisis
Results were analysed for the end point of overall survival. We calculated survival probabilities by the product limit method of Kaplan and Meier (Kaplan and Meier, 1958) . Univariate analysis was assessed using the log-rank test. For multivariate analysis the generalised Cox models (Cox, 1972; Schemper, 1992) (Cardiff, 1994) . Some studies prove high-level cathepsin D expression as an important factor for overall survival in patients with node-negative breast cancer (Tandon et al., 1990) . Cathepsin D is also a well-known prognostic factor for lymph node metastasis in breast cancer (Spyratos et al., 1989) . Other authors do not suppport the prognostic value of cathepsin D or demonstrate controversial results (Henry et al., 1990; Castiglioni et al., 1994 (Rochefort, 1992; Castiglioni et al., 1994; Roger et al., 1994) . In this sense immunohistochemical detection is more specific for the tumour tissue. On the other hand immunohistochemical preparation techniques and reagents are not standardised between the different studies and different antibodies have been used in former investigations (Cardiff, 1994) . Standardised immunohistochemical techniques on well-defined antibodies are important in providing reliable prognostic interpretations of cathepsin D in tumours (Cardiff, 1994 
